Evaluation Inhaled Corticosteroids on Exhaled Nitric Oxide Gas Exchange
Completed
Conditions studied: COPD
In brief
To evaluate the role of inhaled corticosteroids to suppress nitric oxide gas exchange in stable patients with moderate-to-severe COPD who are current non-smokers and not on oral corticosteroids.
Key facts
- Study ID
- NCT00568347
- Run by
- Arthur F Gelb MD
- People needed
- 39
- Starts
- 2006-01-01
- Expected to finish
- 2013-10-01
- Last updated by the study team
- 2015-03-17
Who can join
Age: 20 and older, up to 85. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Clinical diagnosis of copd
- Current non-smoker
- Not on oral corticosteroids
- Must be able to use Advair discus or salmeterol discus
You may not qualify if…
- Pregnancy
- Current smoker
- On corticosteroids
- Clinically unstable
Where it is running
- Arthur F Gelb MD — Lakewood, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.